Claudia Andreetta

Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario

Marta Bonotto, Lorenzo Gerratana, Elena Poletto et al. · The Oncologist · 2014 · 283 citations · Full text

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García et al. · The Lancet · 2023 · 175 citations

Oncology, Cervical Cancer, Metronomic Therapy +6

Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications

Fabio Puglisi, Alessandro Follador, Alessandro Marco Minisini et al. · Annals of Oncology · 2005 · 158 citations · Full text

Baseline Staging Tests, Breast Oncology, Cancer Detection +10

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Thomas Bachelot, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2019 · 111 citations · Full text

Metastatic Breast Cancer, Breast Oncology, Medicine +7

Expression of periostin in human breast cancer

Fabio Puglisi, Cinzia Puppin, Enrico Pegolo et al. · Journal of Clinical Pathology · 2007 · 93 citations